Can you give us your take on the deafening silence from MNTA on the Pfizer plant - moving away to another fill/finish plant?
As has been noted in several posts on this board, MNTA is a third party in this mishap, and hence they can't provide a rolling update for investors. MNTA will say something when there is a consequential development.
Is this quid pro quo between Teva and Novartis/Sandoz/MNTA to delay 40 ml launch?